These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2334157)

  • 21. Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
    Guay D; Tack K; Flor S
    Int J Clin Pharmacol Res; 1991; 11(5):203-9. PubMed ID: 1814841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Jehl F; Burtin P; Dopff C; Pinelli G; Villemot JP; Monteil H; Dureux JB
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2493-6. PubMed ID: 1489193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability and pharmacokinetics of oral ofloxacin formulations in normal subjects.
    Stein GE; LeBel M; Flor SC; Zinny M
    Curr Med Res Opin; 1991; 12(8):479-84. PubMed ID: 1764952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and tissue penetration of enoxacin.
    Wise R; Lockley R; Dent J; Webberly M
    Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
    Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
    Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of acute renal impairment in the penetration of cefoxitin into interstitial tissue fluid in rabbits.
    Dominguez-Gil AA; Garcia MJ; Cepeda M; Lanao JM; Dominguez-Gil A
    Clin Ther; 1981; 3(6):413-24. PubMed ID: 7260987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of antofloxacin in renally impaired rats.
    Pang XY; Liu L; Zhang DM; Wang GJ; Xie L; Liu XD
    J Pharm Pharmacol; 2008 May; 60(5):667-70. PubMed ID: 18416945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous dose.
    Concia E; Cruciani M; Bartucci F; Arrigoni L; Longoni A
    Eur J Clin Pharmacol; 1994; 46(4):371-3. PubMed ID: 7957525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cefetamet in plasma and skin blister fluid.
    Zimmerli W; Sansano S; Wittke B
    Antimicrob Agents Chemother; 1996 Jan; 40(1):102-4. PubMed ID: 8787888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers.
    Walker JS; Knihinicki RD; Seideman P; Day RO
    J Pharm Sci; 1993 Aug; 82(8):787-90. PubMed ID: 8377114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, urinary excretion and plasma protein binding of ofloxacin in water buffalo calves (Bubalus bubalis).
    Ola AK; Sandhu HS; Dumka VK; Ranjan B
    J S Afr Vet Assoc; 2013 Apr; 84(1):E1-5. PubMed ID: 23718538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid.
    Kalager T; Digranes A; Bergan T; Solberg CO
    J Antimicrob Chemother; 1984 May; 13(5):479-85. PubMed ID: 6330020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of brodimoprim in serum and skin blister fluid.
    Kalager T; Digranes A; Salveson A; Bergan T
    Chemotherapy; 1985; 31(6):405-9. PubMed ID: 4075857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram dose.
    Fetterly GJ; Ong CM; Bhavnani SM; Loutit JS; Porter SB; Morello LG; Ambrose PG; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):148-52. PubMed ID: 15616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
    Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
    Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.